These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II. Prajna NV, Krishnan T, Rajaraman R, Patel S, Shah R, Srinivasan M, Das M, Ray KJ, Oldenburg CE, McLeod SD, Zegans ME, Acharya NR, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group. JAMA Ophthalmol; 2017 Sep 01; 135(9):987-991. PubMed ID: 28817744 [Abstract] [Full Text] [Related]
9. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers. Arora R, Gupta D, Goyal J, Kaur R. Clin Exp Ophthalmol; 2011 Jul 01; 39(5):434-40. PubMed ID: 21105974 [Abstract] [Full Text] [Related]
10. Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials. Prajna NV, Lalitha P, Krishnan T, Rajaraman R, Radnakrishnan N, Srinivasan M, Devi L, Das M, Liu Z, Zegans ME, Acharya NR, Porco TC, Lietman TM, Rose-Nussbaumer J. JAMA Ophthalmol; 2022 Feb 01; 140(2):179-184. PubMed ID: 35024776 [Abstract] [Full Text] [Related]
11. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis. Sun CQ, Lalitha P, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM, Mycotic Ulcer Treatment Trial Group. Ophthalmology; 2014 Aug 01; 121(8):1495-500.e1. PubMed ID: 24746358 [Abstract] [Full Text] [Related]